
About Mohammadi Pharma Private Limited
Data last updated:
Mohammadi Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 18 October 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24300MH1994PTC082107.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Denis George Dsouza and Siddesh Niranjan Sigtia.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.28 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.46 Cr (net margin 104.3%) and EBITDA of ₹4.47 Cr (EBITDA margin 104.5%). Revenue has grown at a compounded annual rate (CAGR) of 364% over three years and 61% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spectpharma.com.
Company details
Contact details
Mohammadi Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is spectpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressB – 716 Floor – 7th B Wing Plaza Panchashil Nyaymurti Sitaram Patkar Marg Grant Roa, D, Mumbai, Maharashtra, India – 400007
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
To see the full contact details of Mohammadi Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mohammadi Pharma is financial and insurance service. In detail, this covers other financial activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| K | Financial and insurance Service | K8 | Other financial activities |
To see the full business activity and turnover split of Mohammadi Pharma Private Limited, buy the company report.
Financials of Mohammadi Pharma Private Limited
FY 2025 filings availableMohammadi Pharma Private Limited reported revenue of ₹4.28 Cr (up 85450% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 61% over five years. EBITDA rose 836% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.46 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 104.5% | ||||
| Net Profit Margin | 104.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mohammadi Pharma Private Limited, buy the company report.
Board of directors of Mohammadi Pharma Private Limited
Mohammadi Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Denis George Dsouza Also directs: The Equus Stud Pvt Ltd, Montage Laboratories Private Limited | Director | 24 May 2010 | 16 Years 5 Months | Current |
| Siddesh Niranjan Sigtia Also directs: Sigtia Trade & Logistics LLP, SNS Commodities & Trading LLP, The Equus Stud Pvt Ltd and 1 more | Additional Director | 11 Dec 2024 | 1 Years 10 Months | Current |
Peer comparison
Mohammadi Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other financial activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Matsyagandha Investments Private Limited | ₹4.3 Cr (FY 2025) | -14.0% | Mumbai, Maharashtra, India | |||
| Sri Rajesh Financial and Management Services Private Limited | ₹4.29 Cr (FY 2018) | 8.0% | New Delhi, Delhi, India | |||
| Shubha Maithri Chit Funds Private Limited | ₹4.29 Cr (FY 2024) | 44.0% | Secunderabad, Telangana, India | |||
| Chintan Zaveri Exim Private Limited | ₹4.29 Cr (FY 2025) | 50.0% | Mumbai, Maharashtra, India | |||
| R N Finance Limited | ₹4.28 Cr (FY 2021) | 100.0% | Delhi, India | |||
| Mohammadi Pharma Private Limitedthis company | ₹4.28 Cr (FY 2025) | ₹4.46 Cr | 104.3% | 85450.0% | Mumbai, Maharashtra, India | |
| Novas Commercial Pvt. Ltd. | ₹4.28 Cr (FY 2024) | -9.0% | Katni, Madhya Pradesh, India | |||
| Khedia Finvest (India) Private Limited | ₹4.27 Cr (FY 2025) | -41.0% | Bilaspur, Chhattisgarh, India | |||
| Daniel Vyappar Private Limited | ₹4.27 Cr (FY 2025) | 9199.0% | Howrah, West Bengal, India | |||
| Ang Chit Fund Private Limited | ₹4.27 Cr (FY 2025) | -3.0% | Hyderabad, Telangana, India | |||
| Maham Holdings Private Limited | ₹4.26 Cr (FY 2025) | 22.0% | Chamiers Road, Madras, Tamil Nadu, India |
To see the full peer comparison of Mohammadi Pharma Private Limited, buy the company report.
Auditor
Mohammadi Pharma Private Limited is audited by A M GHELANI & COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A M GHELANI & COMPANY | FY 2017 | 103173W |
Shareholding
The shareholding of Mohammadi Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mohammadi Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mohammadi Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mohammadi Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Mohammadi Pharma has 2 associated companies. This group structure data is as of FY 2017. The table lists each entity with its relationship and holding.
GST
No GST registration is on our record for Mohammadi Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mohammadi Pharma Private Limited has 6 board changes on record since 2008: 2 appointments and 4 cessations. The latest: Hemant Shripat Chavan ceased to be Director on 12 Dec 2024.
Frequently asked questions
Mohammadi Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 18 October 1994 (32+ years old) and is registered under CIN U24300MH1994PTC082107.
Mohammadi Pharma has 2 current directors:
- Denis George Dsouza - Director
- Siddesh Niranjan Sigtia - Additional Director
The latest financial statements of Mohammadi Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Mohammadi Pharma is U24300MH1994PTC082107. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mohammadi Pharma was incorporated on 18 October 1994, making it 32+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Mohammadi Pharma by revenue are Matsyagandha Investments Private Limited, Sri Rajesh Financial and Management Services Private Limited, Shubha Maithri Chit Funds Private Limited, Chintan Zaveri Exim Private Limited, R N Finance Limited and 5 more, all in the same principal business activity (other financial activities).
Hemant Shripat Chavan ceased to be Director on 12 Dec 2024. Siddesh Niranjan Sigtia was appointed as Additional Director on 11 Dec 2024. Shivanand Krishna Shenoy ceased to be Additional Director on 02 Feb 2017. Mohammadi Pharma has 6 board changes on record in total.
Mohammadi Pharma can be reached through the website spectpharma.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Mohammadi Pharma is at B – 716 Floor – 7th B Wing Plaza Panchashil Nyaymurti Sitaram Patkar Marg Grant Roa, D, Mumbai, Maharashtra, India – 400007.
Mohammadi Pharma operates in the food and beverages industry, in the manufacturing segment.
The compliance status of Mohammadi Pharma is compliant as of 16 August 2026. The company is actively filing with the Registrar of Companies.

